2021 should be a banner year for biotech startups that make smart choices early
Michael B. Gray Contributor Michael B. Gray is partner and leader of the private equity, venture capital and growth companies practice, Neal Gerber Eisenberg. John Flavin Contributor < p id=”speakable-summary”>Last year was a record 12 months for venture-backed biotech and pharma companies, with deal activity rising to $28.5 billion from $17.8 billion in 2019. As […]
Posted from: this blog via Microsoft Flow.
Comments
Post a Comment